January 28th, 2013 
matthew 
The European Commission have granted Novo Nordisk approval for the long acting insulin Tresiba (insulin degludec) and Ryzodeg (insulin degludec/insulin aspart) across all European Union member states for diabetic patients. The new treatments from Novo Nordisk can reduce diabetic complications and allow fewer injections according to the company, which if true might be sensational news [...]
Posted in Brands, Insulin, Research, Treatments 
Tags: long acting insulin, Novo Nordisk 
Comments Off April 30th, 2012 matthew Consumer activists such as Public Citizen now ask FDA to ban one of the newest drugs to assist in type Diabetes, Victoza. The main reasons to ban Victoza are because of the increased pancreatic and thyroid cancer risk. So far, at least 28 cased of pancreatic cancer have been diagnosed by patients using Victoza. Usually, this [...]
